IncFact
Company Profiles: Revenue, Growth, Competition

ABCAM Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Abcam

Access the complete profile.

Abcam Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
325414 Biological Product Manufacturing
AddressOne Kendall Square, Bldg 200
3rd Floor, Suite B2304
Cambridge, MA 02139

Note: Revenues for privately held companies are statistical evaluations.


Abcam's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Abcam's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Abcam Annual Revenue and Growth Rate

Abcam Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Abcam's revenues are gauged from an analysis of company filings.



Abcam's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Abcam Revenue (Sales) Abcam Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Abcam is developing and marketing. Abcam doesn't have any recent trademark applications, indicating Abcam is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ABCAM
Antibodies, peptides, enzymes, lysates and vectors all for research purposes
07/07/2003

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Abcam grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Abcam is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of Abcam's Largest Competitors

A competitive analysis shows these companies are in the same general field as Abcam, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
THERADAPTIVELexington, MA46 
BETULA EXTRACTIVESWaconia, MN20 




Nearby Competitors

These companies are similar in business line and location to Abcam. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
INTARCIA THERAPEUTICSBoston, MA100 
ABCAMCambridge, MA74 
BRAINTREE LABORATORIESBraintree, MA55 
MERRIMACK PHARMACEUTICALSCambridge, MA49 
NEUROPHAGE PHARMACEUTICALSCambridge, MA5 
SUMMIT THERAPEUTICSCambridge, MA5 




Future Competition: Abcam's Fastest Growing Competitors

These companies are in the same general field as Abcam and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Abcam Competitors